Cargando…
Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells
Myeloid-derived suppressor cells (MDSCs) were found to gradually accumulate in the orthotopic esophageal cancer mouse model during tumor progression. Although the roles of MDSCs in promoting tumor growth and inhibiting immune response have been extensively explored, currently, there are still no eff...
Autores principales: | Qin, Guohui, Liu, Shasha, Liu, Jinyan, Hu, Hongwei, Yang, Li, Zhao, Qitai, Li, Congcong, Zhang, Bin, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140025/ https://www.ncbi.nlm.nih.gov/pubmed/37105980 http://dx.doi.org/10.1038/s41392-023-01388-6 |
Ejemplares similares
-
MDSCs-derived GPR84 induces CD8(+) T-cell senescence via p53 activation to suppress the antitumor response
por: Liu, Jinyan, et al.
Publicado: (2023) -
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
por: De Cicco, Paola, et al.
Publicado: (2020) -
Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
por: Wang, Yufei, et al.
Publicado: (2020) -
Pro-phagocytic function and structural basis of GPR84 signaling
por: Zhang, Xuan, et al.
Publicado: (2023) -
Pro-phagocytic function and structural basis of GPR84 signaling
por: Zhang, Xuan, et al.
Publicado: (2023)